Pages
Blogroll
- Blood Pressure Risk Factors
- Electric mobility scooters
- Hair Growth Product Reviews
- Hoveround Wheelchairs
- Medical Scales
- Mortgage modification trial payments
- NBA Basketball Betting
- Nursing career
- Pancreas Cancer
- Prevent Cancer
- Prostate Cancer Treatment Side Effects
- Type 2 Diabetes Mellitus
Categories
- Cancer Risk
- Cells and Organs
- General Information
- Prostate Help Organizations
- UK Prostate Cancer
- Uncategorized
Archives
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
Meta
ZD4054 is a potential anti-cancer agent now in a clinical trials around the world for men with metastatic hormone refractory prostate cancer (HRPC) and for men with non-metastatic hormone refractory prostate cancer.
The trials are run by pharmaceutical company AstraZeneca, which makes ZD4054. These two distinct trials differ significantly in the level of therapy offered to [...] (Source: psa-rising.com/blog)
Original post by psa-rising.com/blog and software by Elliott Back
A study published in Clinical Cancer Research August 18 2009 reports that an extract of the Chinese herb Wedelia (a member of the Asteraceae, or sunflower family of plants) shrinks the androgen receptor and prostate cancer in male mice.
“Wedelia chinensis,” the authors write, “is a common ingredient of anti-inflammatory herbal medicines in Taiwan and [...] (Source: psa-rising.com/blog)
Original post by psa-rising.com/blog and software by Elliott Back
Patients who experience fatigue during radiotherapy for breast or prostate cancer may be reacting to activation of the proinflammatory cytokine network, a known inflammatory pathway, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.
â?¢ Fatigue is a major side effect of radiotherapy
â?¢ Inflammation mechanism suggests possible treatment [...] (Source: psa-rising.com/blog)
Original post by psa-rising.com/blog and software by Elliott Back
Colin Powell, tennis champ John McEnroe and L.A. Dodger’s manager Joe Torre come together to save lives! They speak out on one of the deadliest cancers for men! Powell, McEnroe and Torre on surviving and preventing prostate cancer!
Show titled “Saving Lives,” tonight (Friday) – show pages
Email Your questions!
iReport.com: Send your questions via video!
For this alert, [...] (Source: psa-rising.com/blog)
Original post by psa-rising.com/blog and software by Elliott Back
Scientists have made a discovery about antibiotics that may advance cancer therapy. By studying the mechanisms at work in protein production, a Princeton-led team has discovered why certain kinds of antibiotics are so effective.
The new discovery exposes how a specific protein protects against cell death. This may also shed light on the cancer-fighting [...] (Source: psa-rising.com/blog)
Original post by psa-rising.com/blog and software by Elliott Back
In people with cancer angiogenesis involves the growth of tiny new blood vessels to generate a blood supply for tumors. This process has been shown to play an important role in the growth, proliferation and spread of prostate cancer tumors.
Vascular endothelial growth factor (VEGF) is a chemical signal produced by cells that stimulates the [...] (Source: psa-rising.com/blog)
Original post by psa-rising.com/blog and software by Elliott Back
For a glimpse into what your oncologist can learn about prostate cancer this fall check out the agenda for this October 31, 2009 conference. Unfortunately, for prostate cancer this learning session reflects no rapid advancements in standard of care. But if your oncologist falls beneath this standard, find someone better:
Sixth Annual Current Trends in Genitourinary [...] (Source: psa-rising.com/blog)
Original post by psa-rising.com/blog and software by Elliott Back
Androgen-deprivation therapy is well-established for treating prostate cancer but is associated with bone loss and an increased risk of fracture. Matthew R. Smith and an international team investigated the effects of denosumab, a fully human monoclonal antibody against receptor activator of nuclear factor-{kappa}B ligand, on bone mineral density and fractures in men receiving androgen-deprivation therapy [...] (Source: psa-rising.com/blog)
Original post by psa-rising.com/blog and software by Elliott Back
This past weekend we invited my in-laws for Sunday dinner. I have the best mother and father-in law in the world. I love them dearly and hadn’t seen them since my father-in-law’s 90th birthday at the end of June. When their expected time of arrival passed and we didn’t hear from them I started to worry. After they appeared to be more than a half hour late I was really concerned. When they finally showed up at the door over an hour and a half past when I expected them, I was so relieved. Turns out they were delayed by construction and traffic which I hadn’t expected on a Sunday. The afternoon went terrifically and we had a great time with them as usual.
Waiting with concerned anticipation before they showed reminded me of all the times I waited with the same antici…
Original post by Life with Breast Cancer and software by Elliott Back
Hispanics who move to the USA increase their risk of several types of cancer within the first generation. Increased risk of prostate, colorectal and endometrial cancer affect people who move to the USA from Cuba, Mexico, Puerto Rico and other Latin American nations, according to a study published August 1, 2009 in Cancer Epidemiology Biomarkers [...] (Source: psa-rising.com/blog)
Original post by psa-rising.com/blog and software by Elliott Back